• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

连续五年的阿片类药物替代治疗:海洛因使用轨迹和结果。

Continuous opioid substitution treatment over five years: Heroin use trajectories and outcomes.

机构信息

King's College London, Addictions Department, Box 48, Institute of Psychiatry, Psychology and Neuroscience, DeCrespigny Park, Denmark Hill, London, SE5 8AF, United Kingdom; Alcohol, Drugs, Tobacco and Justice Division, Health Improvement Directorate, Public Health England, 7th Floor, Wellington House, 133-155 Waterloo Road, London, SE1 8UG, United Kingdom.

King's College London, Addictions Department, Box 48, Institute of Psychiatry, Psychology and Neuroscience, DeCrespigny Park, Denmark Hill, London, SE5 8AF, United Kingdom.

出版信息

Drug Alcohol Depend. 2018 Jul 1;188:200-208. doi: 10.1016/j.drugalcdep.2018.03.052. Epub 2018 May 16.

DOI:10.1016/j.drugalcdep.2018.03.052
PMID:29778774
Abstract

BACKGROUND

This is the first national study in England of continuous long-term opioid substitution treatment (OST).

METHODS

All adults were admitted to community OST for opioid use disorder (OUD) in 2008/09 with continuous enrolment to 2013/14 (n = 7719). Heroin use trajectories were identified by multilevel Latent Class Growth Analysis. In Year 6 and 7 of follow-up, the outcome measure (analysed by multilevel, multivariable logistic regression) was 'successful completion and no re-presentation' (SCNR) to community treatment within six months.

RESULTS

Five heroin use trajectory classes were identified: 'gradual decreasing' (20.9%), 'decreasing then increasing' (21.7%), 'continued low-level' (17.0%), 'rapid decreasing' (25.6%), and 'continued high-level' (14.8%). At the end of Year 7, 4616 people (60.3%) remained in OST. Of those discharged, 28.8% achieved the SCNR follow-up outcome. SCNR was more likely in the 'gradual decreasing' (adjusted odds ratio [AOR] 2.40; 95% confidence interval [CI] 1.77-3.26), 'continued low-level' (AOR 2.46; CI 1.78-3.40), and 'rapid decreasing' (AOR 3.40; CI 2.43-4.37) classes relative to the 'continued high-level' class. SCNR was more likely among patients employed at admission (AOR 1.45; 95% CI 1.15-1.83) and those receiving adjunctive psychosocial interventions (AOR 1.44; 95% CI 1.03 to 2.02).

CONCLUSIONS

Among English patients in OST for 5 years, heroin use trajectories were clearly delineated with a gradient of response on the study outcome. Successful completion and no re-presentation was achieved by 28.8% of discharged patients. The rapid decreasing trajectory had the greatest likelihood of positive outcome. Adjunctive psychosocial intervention during OST was associated with positive outcome.

摘要

背景

这是在英格兰进行的首次关于持续长期阿片类物质替代治疗(OST)的全国性研究。

方法

2008/09 年,所有成年人因阿片类物质使用障碍(OUD)接受社区 OST,连续登记至 2013/14 年(n=7719)。采用多层次潜在类别增长分析确定海洛因使用轨迹。在第 6 年和第 7 年的随访中,结局测量(采用多层次、多变量逻辑回归分析)为在 6 个月内“成功完成且无再次就诊”(SCNR)至社区治疗。

结果

确定了 5 种海洛因使用轨迹类别:“逐渐减少”(20.9%)、“减少后增加”(21.7%)、“持续低水平”(17.0%)、“快速减少”(25.6%)和“持续高水平”(14.8%)。在第 7 年末,4616 人(60.3%)仍在 OST 中。在出院者中,28.8%达到 SCNR 随访结局。与“持续高水平”类别相比,“逐渐减少”(调整后的优势比[OR]2.40;95%置信区间[CI]1.77-3.26)、“持续低水平”(OR 2.46;CI 1.78-3.40)和“快速减少”(OR 3.40;CI 2.43-4.37)类别更有可能达到 SCNR。在入院时就业的患者(OR 1.45;95%CI 1.15-1.83)和接受辅助心理社会干预的患者(OR 1.44;95%CI 1.03-2.02)中,SCNR 更有可能发生。

结论

在接受 OST 治疗 5 年的英国患者中,海洛因使用轨迹明显不同,研究结局存在差异。在出院患者中,有 28.8%达到了成功完成且无再次就诊的目标。快速减少轨迹具有最大的积极结果可能性。OST 期间辅助心理社会干预与积极结果相关。

相似文献

1
Continuous opioid substitution treatment over five years: Heroin use trajectories and outcomes.连续五年的阿片类药物替代治疗:海洛因使用轨迹和结果。
Drug Alcohol Depend. 2018 Jul 1;188:200-208. doi: 10.1016/j.drugalcdep.2018.03.052. Epub 2018 May 16.
2
Change in alcohol and other drug use during five years of continuous opioid substitution treatment.五年阿片类物质替代治疗期间酒精和其他药物使用的变化。
Drug Alcohol Depend. 2019 Jan 1;194:438-446. doi: 10.1016/j.drugalcdep.2018.11.008. Epub 2018 Nov 26.
3
Effectiveness of treatment for opioid use disorder: A national, five-year, prospective, observational study in England.阿片类物质使用障碍的治疗效果:一项在英格兰开展的全国性、为期五年的前瞻性观察性研究。
Drug Alcohol Depend. 2017 Jul 1;176:139-147. doi: 10.1016/j.drugalcdep.2017.03.013. Epub 2017 May 16.
4
Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England.在监狱接受阿片类药物替代治疗能否降低释放后死亡风险?一项在英格兰开展的全国性前瞻性观察研究。
Addiction. 2017 Aug;112(8):1408-1418. doi: 10.1111/add.13779. Epub 2017 Mar 1.
5
Opioid substitution treatment and heroin dependent adolescents: reductions in heroin use and treatment retention over twelve months.阿片类物质替代治疗和海洛因依赖青少年:12 个月内海洛因使用和治疗保留率的降低。
BMC Pediatr. 2018 May 4;18(1):151. doi: 10.1186/s12887-018-1137-4.
6
Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.在一项快速阿片类药物替代治疗可行性随机对照试验中增强动机:一项嵌套式定性研究
Subst Abuse Treat Prev Policy. 2014 Nov 18;9:44. doi: 10.1186/1747-597X-9-44.
7
Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack.海洛因单一使用者和海洛因及冰毒双重使用者阿片类药物替代疗法中戒毒的预测因素。
Addict Behav. 2018 Feb;77:210-216. doi: 10.1016/j.addbeh.2017.10.013. Epub 2017 Oct 18.
8
Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.在接受和未接受阿片类药物替代疗法的注射吸毒者中,多药物使用模式和与药物相关结果的差异。
Addiction. 2016 Jul;111(7):1214-23. doi: 10.1111/add.13339. Epub 2016 Apr 3.
9
Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).难以治疗的海洛因成瘾者接受监督注射阿片类药物治疗的药物使用、健康和社会结局:随机注射阿片类药物治疗试验(RIOTT)的次要结局。
Addiction. 2015 Mar;110(3):479-90. doi: 10.1111/add.12748. Epub 2014 Nov 7.
10
Effectiveness of community psychosocial and pharmacological treatments for alcohol use disorder: A national observational cohort study in England.社区心理社会和药物治疗酒精使用障碍的效果:英格兰的一项全国观察性队列研究。
Drug Alcohol Depend. 2018 May 1;186:60-67. doi: 10.1016/j.drugalcdep.2018.01.019. Epub 2018 Mar 13.

引用本文的文献

1
Desirable treatment or a problematic drug scene? - An interview study of patients' and professionals' views on the risks and benefits of liberalized opioid agonist treatment.理想的治疗方法还是有问题的药物场景?——一项关于患者和专业人员对放宽阿片类激动剂治疗的风险和益处看法的访谈研究
Harm Reduct J. 2025 Apr 4;22(1):47. doi: 10.1186/s12954-025-01197-w.
2
Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial.每月一次缓释丁丙诺啡与每日标准护理药物相比的优越性和成本效益:一项实用、平行组、开放标签、多中心、随机、对照的3期试验。
EClinicalMedicine. 2023 Nov 17;66:102311. doi: 10.1016/j.eclinm.2023.102311. eCollection 2023 Dec.
3
The effect of employment support integrated in substance use treatment: A health economic cost-effectiveness simulation of three different interventions.纳入物质使用治疗的就业支持效果:三种不同干预措施的健康经济成本效益模拟
Nordisk Alkohol Nark. 2023 Apr;40(2):199-211. doi: 10.1177/14550725221122196. Epub 2022 Nov 7.
4
The association between drug use and mortality in a norwegian prison cohort: a prospective cohort study.挪威监狱队列中药物使用与死亡率之间的关联:一项前瞻性队列研究。
Health Justice. 2023 Apr 14;11(1):22. doi: 10.1186/s40352-023-00223-y.
5
Patterns and Predictors of Heroin Use, Remission, and Psychiatric Health Among People with Heroin Dependence: Key Findings from the 18-20-Year Follow-Up of the Australian Treatment Outcome Study (ATOS).海洛因依赖者中海洛因使用、缓解及精神健康的模式与预测因素:澳大利亚治疗结果研究(ATOS)18 - 20年随访的关键发现
Int J Ment Health Addict. 2023 Jan 18:1-18. doi: 10.1007/s11469-022-01006-6.
6
The subjective experience of heroin effects among individuals with chronic opioid use: Revisiting reinforcement in an exploratory study.慢性阿片类药物使用者对海洛因作用的主观体验:一项探索性研究中的强化再探讨。
Addict Neurosci. 2022 Dec;4. doi: 10.1016/j.addicn.2022.100034. Epub 2022 Aug 28.
7
Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone.用于治疗阿片类药物使用障碍的延长释放型药物治疗(EXPO):一项关于注射用丁丙诺啡与舌下含服丁丙诺啡片和口服美沙酮液有效性和成本效益的开放性随机对照试验的方案。
Trials. 2022 Aug 19;23(1):697. doi: 10.1186/s13063-022-06595-0.
8
Structural violence and the need for compassionate use of methadone in Mexico.结构性暴力与在墨西哥对美沙酮进行同情性使用的必要性。
BMC Public Health. 2022 Mar 29;22(1):606. doi: 10.1186/s12889-022-12955-x.
9
The effect evaluation of Individual Placement and Support (IPS) for patients with substance use disorders: study protocol for a randomized controlled trial of IPS versus enhanced self-help.个体安置和支持(IPS)对物质使用障碍患者的效果评价:IPS 与增强自助对照随机临床试验研究方案。
Trials. 2021 Oct 15;22(1):705. doi: 10.1186/s13063-021-05673-z.
10
Longitudinal K-means approaches to clustering and analyzing EHR opioid use trajectories for clinical subtypes.纵向 K 均值方法在聚类和分析电子健康记录阿片类药物使用轨迹中的临床亚型的应用。
J Biomed Inform. 2021 Oct;122:103889. doi: 10.1016/j.jbi.2021.103889. Epub 2021 Aug 16.